Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Reville, Patrick K
[Clear All Filters]
2024
Fiskus W
,
Piel J
,
Collins MP
,
Hentemann M
,
Cuglievan B
,
Mill CP
,
Birdwell C
,
Das K
,
Davis JA
,
Hou H
, et al.
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor.
Blood. 2024.
PubMed
Google Scholar
2023
Desai PN
,
Wang B
,
Fonseca A
,
Borges P
,
Jelloul FZahra
,
Reville PK
,
Lee E
,
Ly C
,
Basi A
,
Root J
, et al.
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion.
Cancer Immunol Res. 2023:OF1-OF18.
PubMed
Google Scholar
2022
Kadia TM
,
Reville PK
,
Wang X
,
Rausch CR
,
Borthakur G
,
Pemmaraju N
,
Daver NG
,
Dinardo CD
,
Sasaki K
,
Issa GC
, et al.
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia.
J Clin Oncol. 2022:JCO2102823.
PubMed
Google Scholar
Lachowiez CA
,
Reville PK
,
Kantarjian H
,
Jabbour E
,
Borthakur G
,
Daver N
,
Loghavi S
,
Furudate K
,
Xiao L
,
Pierce S
, et al.
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study.
Lancet Haematol. 2022;9(5):e350-e360.
PubMed
Google Scholar